{"anticipatedPostingDate":"2026-12","denomUnitsSelected":"Participants","description":"DRSS2 is defined as the time from randomization to the first documented local recurrence with visceral lesion or occurrence of distant kidney cancer metastasis(es) with visceral lesion, whichever occurs first, as assessed by the investigator.","reportingStatus":"NOT_POSTED","timeFrame":"Up to approximately 72 months","title":"Second Disease Recurrence-Specific Survival (DRSS2) as Assessed by the Investigator","type":"SECONDARY"}